Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADIONET: Radioguided Surgery for Neuroendocrine Tumors
NCT04296149Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Feb 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by European Institute of Oncology. Primary endpoint: Evaluation of sensitivity of a beta- probe at 2 years. Started Feb 2017; status: completed.
Beyond the preview
Go deeper on NCT04296149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04296149.